Close
1Unless stated otherwise, all notification data is AHPRA data.
The Podiatry Board of Australia’s revised registration standard for endorsement for scheduled medicines and associated guidelines took effect on 1 August 2018.
Supplementary materials to support podiatrists and podiatric surgeons using Pathway B of the new registration standard, such as FAQ and templates, were developed and published by the Board. This included a Prescribing Self-Assessment Tool, designed to support practitioners’ learning by providing an opportunity to reflect on their current skills and knowledge, compared to those recognised as essential for safe and effective prescribing of medicines. The aim of the tool is that practitioners will use it to identify areas in which they feel they have the required prescribing competencies, as well as to identify specific knowledge and skills that require improvement before finishing their period of supervised practice under Pathway B and submitting their application for endorsement. Although optional, completion of the self-assessment is encouraged by the Board as an important component of learning as practitioners progress through Pathway B to endorsement.
Two animated videos to present information about Pathway B in a different format were also developed and published by the Board. One video explains the steps for Pathway B, and the other highlights the role a mentor plays in supporting a practitioner’s learning during the supervised practice period under Pathway B.
The Board informed the profession about the requirements of the revised registration standard through its regular newsletters and communiqués, and presentations at association events in Perth and Adelaide. It also hosted a booth at the Australian Podiatry Conference 2019, where Board members answered questions about the requirements for endorsement and explained where practitioners could find information about the process on the Board’s website.
Following a scheduled review of accreditation arrangements that was undertaken across all National Boards, the Board decided in July 2018 that the accreditation functions for the podiatry profession will be exercised by an independent accreditation committee established by the Board for a five-year period from 1 July 2019.
The Australian and New Zealand Podiatry Accreditation Council (ANZPAC) continued to accredit and monitor podiatry and podiatric surgery education programs and assess overseas qualified podiatrists up to 30 June 2019. The Board, AHPRA and ANZPAC worked together to ensure a smooth transition of the accreditation work to the Podiatry Accreditation Committee (the committee) on 1 July 2019. After a competitive expression of interest and selection process, the Board appointed seven members to the committee. Committee members attended an induction day in June 2019 and the committee will start undertaking the accreditation functions from 1 July 2019.
The Board continued to include messages in its newsletter reminding practitioners about the importance of effective infection prevention and control in providing quality healthcare for patients and a safe working environment for those who work in healthcare settings. Practitioners were encouraged to use the Board’s self-audit tool as a checklist to ensure their workplace is clean and hygienic and they are taking the necessary feasible steps to prevent or minimise the spread of infection.
The Board continued to engage with its key stakeholders, including the Australian Podiatry Association; the Podiatry Council of New South Wales; ANZPAC; the Podiatrists Board of New Zealand; and local stakeholders in Adelaide and Brisbane. The Board also hosted a booth at the Australian Podiatry Conference 2019 in Adelaide and welcomed the opportunity to meet with registrants.
Dr Cylie Williams PhD, Chair